-
Je něco špatně v tomto záznamu ?
Heart Rate Variability Analysis in Congestive Heart Failure: The Need for Standardized Assessment Protocols
M. Míková, D. Pospíšil, J. Řehoř, M. Malik
Status neindexováno Jazyk angličtina Země Singapur
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2018
PubMed Central
od 2022
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
40475734
DOI
10.31083/rcm36321
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Heart rate variability (HRV) analysis is a noninvasive tool that allows cardiac autonomic control to be assessed. Numerous studies have reported HRV measurements, related changes, and clinical implications for heart failure patients. This review evaluates HRV characteristics in congestive heart failure (CHF), focusing on different recording durations and the diagnostic and prognostic values using HRV measurements. The recording durations are classified as (a) ultra short-term (substantially shorter than 5 minutes), (b) short-term (5 minutes), and (c) long-term (nominal 24 hours). This review of HRV diagnostic and prognostic significance in CHF focuses on time- and frequency-domain HRV measures that have previously been extensively studied. Reported studies document that HRV is lowered in CHF patients, whereas HRV increases may indicate disease improvement, e.g., in CHF patients undergoing cardiac resynchronization therapy. Reduced HRV has consistently been found to be associated with all-cause mortality in CHF patients. However, different thresholds of long-term HRV indices have been proposed as mortality predictors; meanwhile, findings related to the prediction of other cardiac events, including sudden cardiac death, remain inconsistent. HRV is reduced in CHF patients, but the use of HRV as a risk factor remains controversial, with no established cut-off values. HRV does not provide a clinically useful prediction of sudden cardiac death or other cardiac events in CHF patients. Thus, we advocate standardization of investigative protocols based on the existing time- and frequency-domain HRV indices rather than further developing more complex methods. Short-term recordings are preferable for clinical application and measurement reproducibility; thus, future investigations should focus on the following key questions: 1. How to design standardized short HRV tests suitable for outpatient settings? 2. Which HRV indices should be preferred, and what are their optimal prognostic thresholds? 3. How to standardize HRV assessment conditions to minimize external influences?
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25014302
- 003
- CZ-PrNML
- 005
- 20250905141416.0
- 007
- ta
- 008
- 250701s2025 si f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.31083/RCM36321 $2 doi
- 035 __
- $a (PubMed)40475734
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a si
- 100 1_
- $a Míková, Monika $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine of Masaryk University, 625 00 Brno, Czech Republic $1 https://orcid.org/0000000170401967
- 245 10
- $a Heart Rate Variability Analysis in Congestive Heart Failure: The Need for Standardized Assessment Protocols / $c M. Míková, D. Pospíšil, J. Řehoř, M. Malik
- 520 9_
- $a Heart rate variability (HRV) analysis is a noninvasive tool that allows cardiac autonomic control to be assessed. Numerous studies have reported HRV measurements, related changes, and clinical implications for heart failure patients. This review evaluates HRV characteristics in congestive heart failure (CHF), focusing on different recording durations and the diagnostic and prognostic values using HRV measurements. The recording durations are classified as (a) ultra short-term (substantially shorter than 5 minutes), (b) short-term (5 minutes), and (c) long-term (nominal 24 hours). This review of HRV diagnostic and prognostic significance in CHF focuses on time- and frequency-domain HRV measures that have previously been extensively studied. Reported studies document that HRV is lowered in CHF patients, whereas HRV increases may indicate disease improvement, e.g., in CHF patients undergoing cardiac resynchronization therapy. Reduced HRV has consistently been found to be associated with all-cause mortality in CHF patients. However, different thresholds of long-term HRV indices have been proposed as mortality predictors; meanwhile, findings related to the prediction of other cardiac events, including sudden cardiac death, remain inconsistent. HRV is reduced in CHF patients, but the use of HRV as a risk factor remains controversial, with no established cut-off values. HRV does not provide a clinically useful prediction of sudden cardiac death or other cardiac events in CHF patients. Thus, we advocate standardization of investigative protocols based on the existing time- and frequency-domain HRV indices rather than further developing more complex methods. Short-term recordings are preferable for clinical application and measurement reproducibility; thus, future investigations should focus on the following key questions: 1. How to design standardized short HRV tests suitable for outpatient settings? 2. Which HRV indices should be preferred, and what are their optimal prognostic thresholds? 3. How to standardize HRV assessment conditions to minimize external influences?
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Pospíšil, David $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine of Masaryk University, 625 00 Brno, Czech Republic $1 https://orcid.org/0000000261735225
- 700 1_
- $a Řehoř, Jan $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine of Masaryk University, 625 00 Brno, Czech Republic
- 700 1_
- $a Malik, Marek $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine of Masaryk University, 625 00 Brno, Czech Republic $u National Heart and Lung Institute, Imperial College, ICTEM Building, Hammersmith Campus, W12 0NN London, UK $1 https://orcid.org/0000000237921407 $7 xx0098959
- 773 0_
- $w MED00203331 $t Reviews in cardiovascular medicine $x 2153-8174 $g Roč. 26, č. 5 (2025), s. 36321
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40475734 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250701 $b ABA008
- 991 __
- $a 20250905141404 $b ABA008
- 999 __
- $a ok $b bmc $g 2388037 $s 1251422
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 26 $c 5 $d 36321 $e 20250526 $i 2153-8174 $m Reviews in cardiovascular medicine $n Rev Cardiovasc Med $x MED00203331
- LZP __
- $a Pubmed-20250701